BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23708871)

  • 21. Effects of postoperative antioxidants on the salivary glands in patients with thyroid cancer undergoing radioactive iodine-131 treatment.
    Tong H; Yue R; Fang J; Li X; Yang S; Hou Y; Wang R; Zhang B; Liu H; Wu Z; Cheng Y
    Nucl Med Commun; 2024 Apr; 45(4):312-320. PubMed ID: 38312062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amifostine is a potent radioprotector of salivary glands in radioiodine therapy. Structural and ultrastructural findings.
    Kutta H; Kampen U; Sagowski C; Brenner W; Bohuslavizki KH; Paulsen F
    Strahlenther Onkol; 2005 Apr; 181(4):237-45. PubMed ID: 15827693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Quantitative salivary gland scintigraphy--a recommended examination prior to and after radioiodine therapy].
    Bohuslavizki KH; Brenner W; Lassmann S; Tinnemeyer S; Kalina S; Clausen M; Henze E
    Nuklearmedizin; 1997 Apr; 36(3):103-9. PubMed ID: 9162904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin E protects salivary glands dysfunction induced by ionizing radiation in rats.
    Abedi SM; Yarmand F; Motallebnejad M; Seyedmajidi M; Moslemi D; Ashrafpour M; Bijani A; Moghadamnia A; Mardanshahi A; Hosseinimehr SJ
    Arch Oral Biol; 2015 Sep; 60(9):1403-9. PubMed ID: 26150230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Preventive Effect of Parotid Gland Massage on Salivary Gland Dysfunction During High-Dose Radioactive Iodine Therapy for Differentiated Thyroid Cancer: A Randomized Clinical Trial.
    Son SH; Lee CH; Jung JH; Kim DH; Hong CM; Jeong JH; Jeong SY; Lee SW; Lee J; Ahn BC
    Clin Nucl Med; 2019 Aug; 44(8):625-633. PubMed ID: 31274608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited cytoprotective effects of amifostine in high-dose radioactive iodine 131-treated well-differentiated thyroid cancer patients: analysis of quantitative salivary scan.
    Kim SJ; Choi HY; Kim IJ; Kim YK; Jun S; Nam HY; Kim JS
    Thyroid; 2008 Mar; 18(3):325-31. PubMed ID: 18341378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salivary gland function in thyroid cancer patients with radioiodine administration history.
    Krcalova E; Horacek J; Gabalec F; Zak P; Dolezal J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Sep; 164(3):277-283. PubMed ID: 31223135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment.
    Caglar M; Tuncel M; Alpar R
    Clin Nucl Med; 2002 Nov; 27(11):767-71. PubMed ID: 12394122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salivary and lacrimal gland dysfunction after remnant ablation with radioactive iodine in patients with differentiated thyroid carcinoma prepared with recombinant human thyrotropin.
    Rosario PW; Calsolari MR
    Thyroid; 2013 May; 23(5):617-9. PubMed ID: 23136908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer.
    Ma C; Xie J; Chen Q; Wang G; Zuo S
    Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD007956. PubMed ID: 19821441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of salivary gland dysfunction after radioiodine therapy for thyroid carcinoma using non-contrast-enhanced CT: the significance of changes in volume and attenuation of the glands.
    Nabaa B; Takahashi K; Sasaki T; Okizaki A; Aburano T
    AJNR Am J Neuroradiol; 2012 Nov; 33(10):1964-70. PubMed ID: 22555571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancer.
    Jentzen W; Schneider E; Freudenberg L; Eising EG; Görges R; Müller SP; Brandau W; Bockisch A
    Nucl Med Commun; 2006 Aug; 27(8):669-76. PubMed ID: 16829767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioprotection of salivary glands by S-2-(3-aminopropylamino)-ethylphosphorothioic (amifostine) obtained in a rabbit animal model.
    Bohuslavizki KH; Klutmann S; Jenicke L; Brenner W; Feyerabend B; Henze E; Clausen M
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):181-6. PubMed ID: 10477022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioiodine-Induced Salivary Gland Damage Detected by Ultrasonography in Patients Treated for Papillary Thyroid Cancer: Radioactive Iodine Activity and Risk.
    Horvath E; Skoknic V; Majlis S; Tala H; Silva C; Castillo E; Whittle C; Niedmann JP; González P
    Thyroid; 2020 Nov; 30(11):1646-1655. PubMed ID: 32370663
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study.
    Klein Hesselink EN; Brouwers AH; de Jong JR; van der Horst-Schrivers AN; Coppes RP; Lefrandt JD; Jager PL; Vissink A; Links TP
    J Nucl Med; 2016 Nov; 57(11):1685-1691. PubMed ID: 27339871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy.
    Solans R; Bosch JA; Galofré P; Porta F; Roselló J; Selva-O'Callagan A; Vilardell M
    J Nucl Med; 2001 May; 42(5):738-43. PubMed ID: 11337569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodine.
    Bohuslavizki KH; Brenner W; Lassmann S; Tinnemeyer S; Tönshoff G; Sippel C; Wolf H; Clausen M; Henze E
    Nucl Med Commun; 1996 Aug; 17(8):681-6. PubMed ID: 8878127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation.
    Grewal RK; Larson SM; Pentlow CE; Pentlow KS; Gonen M; Qualey R; Natbony L; Tuttle RM
    J Nucl Med; 2009 Oct; 50(10):1605-10. PubMed ID: 19759114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of risk for symptomatic sialadenitis by post-therapeutic dual (131)I scintigraphy in patients with differentiated thyroid cancer.
    Lee SM; Lee JW; Kim SY; Han SW; Bae WK
    Ann Nucl Med; 2013 Oct; 27(8):700-9. PubMed ID: 23921836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of radioprotective effect of vitamin E in salivary dysfunction in irradiated rats.
    Ramos FM; Pontual ML; de Almeida SM; Bóscolo FN; Tabchoury CP; Novaes PD
    Arch Oral Biol; 2006 Feb; 51(2):96-101. PubMed ID: 16087151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.